UNH vs CVS
UNH and CVS side by side — valuation & fundamentals (public data).
Key statistics
| Metric | UNHUnitedHealth Group Incorporated | CVSCVS HEALTH CORPORATION |
|---|---|---|
| Market cap | $340.07B | $121.08B |
| P/E (TTM) | 24.3 | 25.0 |
| P/B | 10.30 | 1.52 |
| P/S | 0.8x | 0.3x |
| Dividend yield | 2.33% | 2.81% |
| Revenue | $450.13B(TTM) | $415.09B(TTM) |
| Revenue growth (YoY) | 11.8% | 7.8% |
| Net income | $14.12B(TTM) | $4.89B(TTM) |
| Earnings growth (YoY) | -16.3% | -61.7% |
| EPS, diluted | $15.56(TTM) | $3.79(TTM) |
| EBIT margin | 4.2% | 1.2% |
| ROE | 36.5% | 2.2% |
| ROIC | 21.3% | 2.9% |
| Piotroski F | — | 6/9 |
| 1y total return | +9.6% | +30.4% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: UNH frente a CVS
| Métrica | UNH | CVS |
|---|---|---|
| Valor final | $33.6K | $12.2K |
| Retorno total | +236.3% | +22.0% |
| CAGR | +12.4% | +1.9% |
| Volatilidad | 29.9% | 28.7% |
| Sharpe | 0.41 | 0.07 |
| Sortino | 0.56 | 0.10 |
| Caída máxima | -61.4% | -56.8% |
Basado en 2600 días de negociación comunes, 2016-05-10 → 2026-09-11 · tasa libre de riesgo 4.07% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)